First Author: H.Kolli UK
Co Author(s): M. Mohyudin P. Stavrou H. Kolli 0 0 0 0 0 0 0 0 0
Back to previous
To evaluate the visual acuity (VA) and central retinal thickness (CRT) from OCT scans following subtenon triamcinolone injection in the management of uveitic macular oedema.
Outpatient uveitis clinics in Birmingham and Midland eye centre.
Retrospective analysis of 18 (27 eyes) patients with uveitic macular oedema treated with 40 mg subtenon Triamcinalone. Outcome measures were Log Mar visual acuity (VA) and OCT measured CRT, pre injection, 6 weeks, 3 months and 6 months after the injection.
We studied 27 eyes in 18 patients (Males 4, mean age 49.4, range 23-74). Base line mean CRT decreased from 451.5 μm to 305.3 μm, (p < 0.0004) at 6 weeks, 321.5 μm (p < 0.0018) at 3 months and 343.16 μm (p < 0.0045) at 6 months. Base line Mean Log Mar VA improved from 0.57 pre injection to 0.41 at 6 weeks (p 0.02), 0.46 at 3 months (p 0.13) and 0.48 at 6 months (p 0.44). Three patients (3 eyes) received one repeat injection after one year while one patient (one eye) received it after two years. Complications included transient raised intraocular pressure in six eyes in six patients and persistent ptosis in one eye of a patient.
Posterior subtenon triamcinolone injection significantly decreases macular oedema with improvement in visual acuity in patients with uveitis. The technique has a high level of patient acceptability with few complications.